This is a Validated Antibody Database (VAD) review about dog LOC100856270, based on 5 published articles (read how Labome selects the articles), using LOC100856270 antibody in all methods. It is aimed to help Labome visitors find the most suited LOC100856270 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
LOC100856270 synonym: FCGR2B; low affinity immunoglobulin gamma Fc region receptor II; low affinity immunoglobulin gamma Fc region receptor II-b; Fc fragment of IgG, low affinity IIb, receptor (CD32)
Bio-Rad
mouse monoclonal (AT10) |
| In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, Bio-Rad LOC100856270 antibody (AbD Serotec, MCA1075PE) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi |
mouse monoclonal (AT10) |
| Bio-Rad LOC100856270 antibody (AbD Serotec, AT10) was used in flow cytometry on human samples (fig 1a). Haematologica (2016) ncbi |
mouse monoclonal (AT10) |
| Bio-Rad LOC100856270 antibody (AbD Serotec, AT10) was used in flow cytometry on hamsters samples . PLoS ONE (2014) ncbi |
mouse monoclonal (AT10) |
| Bio-Rad LOC100856270 antibody (Serotec, MCA1075) was used in immunohistochemistry - frozen section on human samples at 1:2000 and in flow cytometry on human samples at 1:500. J Neuroinflammation (2013) ncbi |
Invitrogen
mouse monoclonal (AT10) |
| In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Invitrogen LOC100856270 antibody (Invitrogen, AT10) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi |
Articles Reviewed
- Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments